Literature DB >> 7751319

Specific protein interacting with a tumor promoter, debromoaplysiatoxin, in bovine serum is alpha 1-acid glycoprotein.

H Ueyama1, I Sasaki, K Shimomura, M Suganuma.   

Abstract

Aplysiatoxin and debromoaplysiatoxin, a debrominated form of aplysiatoxin, have both been shown to be potent tumor promoters in a two-stage carcinogenesis experiment on mouse skin. However, debromoaplysiatoxin did not behave like aplysiatoxin in most of the biological assay systems using cultured cells. The discrepancy was supposed to be due to a factor in the bovine serum used for culture, a similar factor not being present in sera of eight other animal species examined. The factor was purified to homogeneity from bovine serum by ammonium sulfate fractionation and chromatographies on DEAE-cellulose, Sephadex G-150, hydroxyapatite, and a reversed-phase HPLC column. The factor was a 40-kDa protein, and partial amino-acid sequencing of its tryptic peptides indicated that the factor is alpha 1-acid glycoprotein. Both the purified factor and the commercially available bovine alpha 1-acid glycoprotein abolished in vitro the activation of protein kinase C by debromoaplysiatoxin but not that by aplysiatoxin. Debromoaplysiatoxin induced differentiation of HL-60 cells into macrophages at a comparable concentration to aplysiatoxin, when serum-free medium was used. These results suggest that alpha 1-acid glycoprotein, which interacts specifically with debromoaplysiatoxin, contained in bovine serum must have masked the in vitro properties of the tumor promoter in the biological assay systems.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7751319     DOI: 10.1007/BF01366964

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  29 in total

1.  Molecular cloning and nucleotide sequence of complementary DNA encoding rabbit alpha 1-acid glycoprotein.

Authors:  B K Ray; A Ray
Journal:  Biochem Biophys Res Commun       Date:  1991-07-31       Impact factor: 3.575

2.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

3.  Estimation of tumor promoting activity and structure-function relationships of aplysiatoxins.

Authors:  M Suganuma; H Fujiki; T Tahira; C Cheuk; R E Moore; T Sugimura
Journal:  Carcinogenesis       Date:  1984-03       Impact factor: 4.944

4.  Activation of the EBV-cycle and aggregation of human blood lymphocytes by the tumor promoters teleocidin, lyngbyatoxin A, aplysiatoxin and debromoaplysiatoxin.

Authors:  L Eliasson; B Kallin; M Patarroyo; G Klein; H Fujiki; T Sugimura
Journal:  Int J Cancer       Date:  1983-01-15       Impact factor: 7.396

5.  Comparative effects of aplysiatoxin, debromoaplysiatoxin, and teleocidin on receptor binding and phospholipid metabolism.

Authors:  A D Horowitz; H Fujiki; I B Weinstein; A Jeffrey; E Okin; R E Moore; T Sugimura
Journal:  Cancer Res       Date:  1983-04       Impact factor: 12.701

6.  Increase in the synthesis of a Mr 32,000 protein in BALB/c 3T3 cells treated with tumor-promoting indole alkaloids or polyacetates.

Authors:  T Hiwasa; H Fujiki; T Sugimura; S Sakiyama
Journal:  Cancer Res       Date:  1983-12       Impact factor: 12.701

7.  Inhibition of phorbol ester-receptor binding by a factor from human serum.

Authors:  A D Horowitz; E Greenebaum; M Nicolaides; K Woodward; I B Weinstein
Journal:  Mol Cell Biol       Date:  1982-05       Impact factor: 4.272

8.  Control of malaria virulence by alpha 1-acid glycoprotein (orosomucoid), an acute-phase (inflammatory) reactant.

Authors:  M J Friedman
Journal:  Proc Natl Acad Sci U S A       Date:  1983-09       Impact factor: 11.205

9.  Stimulation of human monocyte oxidative burst and related cytotoxicity by tumor-promoting and non-tumor-promoting diterpene esters, indole alkaloids and polyacetate-type agents.

Authors:  Y Keisari; I Geva; E Flescher; H Goldin; G Lavie
Journal:  Int J Cancer       Date:  1985-10-15       Impact factor: 7.396

10.  Activation of cytotoxic activity of human blood lymphocytes by tumor-promoting compounds.

Authors:  O F Ramos; M G Masucci; E Klein
Journal:  Cancer Res       Date:  1984-05       Impact factor: 12.701

View more
  1 in total

1.  The effect of type 1 IFN on human aortic endothelial cell function in vitro: relevance to systemic lupus erythematosus.

Authors:  John A Reynolds; David W Ray; Leo A H Zeef; Terence O'Neill; Ian N Bruce; M Yvonne Alexander
Journal:  J Interferon Cytokine Res       Date:  2014-01-20       Impact factor: 2.607

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.